In an expansion of its biomedical education curricula, Weill Cornell Medicine is launching an additional site for graduate programs at Houston Methodist for the 2021-22 academic year.
A new study identifies the mechanism for tolerance to penicillin and related antibiotics in bacteria, findings that could lead to new therapies that boost the effectiveness of these treatments.
Finding innovative solutions for cities’ most pressing problems is a primary goal of the new Urban Tech Hub, part of the Jacobs Technion-Cornell Institute at Cornell Tech.
The discovery of an “Achilles’ heel” in a type of gut bacteria that causes intestinal inflammation in patients with Crohn’s disease may lead to more targeted therapies for the difficult-to-treat disease, researchers have found.
The visiting critic discusses the importance of social design shaped by community partnerships, and a collaboration with AAP students and Black high schoolers in Brooklyn.
A type of cell widely used for brain research and drug development may have been leading researchers astray for years, according to a study from scientists at Weill Cornell Medicine and Columbia University.
Researchers at Weill Cornell Medicine and Cornell’s Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
A $10 million gift to the College of Architecture, Art and Planning has been given to the college by a multi-generational Cornellian family to name and permanently fund its NYC program.
The new, collaborative Precision Behavioral Health Initiative aims to use both smart devices and artificial intelligence to help individuals, and their doctors, monitor and manage behavioral health.
